Revenue, last quarter
$426.2K
−17.3% vs same quarter last year
Net income
−$26.4K
+90.1% vs same quarter last year
EPS, diluted
$0.00
Operating cash flow
$26.6K
−29.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.9M | −$1.5M |
| FY24 | $2.3M | −$23.1M |
| FY23 | $3.4M | −$3.6M |
| FY22 | $42.2K | −$78.3K |
| FY21 | $198.6K | −$96.9K |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 81.1% | −67.1% | −83.2% |
| FY24 | 70.9% | −972.7% | −985.2% |
| FY23 | 67.8% | −99.9% | −105.5% |
| FY22 | 100% | −185.7% | −185.7% |
| FY21 | 99.7% | −83.1% | −48.8% |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $29.9K |
| FY24 | −$513.5K |
| FY23 | −$1.5M |
| FY22 | - |
| FY21 | - |
| FY20 | - |
- Bioregenx
- Technology median
Show the numbers
| Year | Bioregenx | Technology median |
|---|---|---|
| FY25 | −83.2% | 0% |
| FY24 | −985.2% | −1.8% |
| FY23 | −105.5% | −5.8% |
| FY22 | −185.7% | −5.1% |
| FY21 | −48.8% | −4.3% |
| FY20 | - | −7.9% |
News
No stories filed under Bioregenx yet - coverage appears here as the news feed clusters it.